A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects
- First Posted Date
- 2012-02-29
- Last Posted Date
- 2015-09-04
- Lead Sponsor
- High Point Pharmaceuticals, LLC.
- Target Recruit Count
- 126
- Registration Number
- NCT01540864
- Locations
- ๐บ๐ธ
Site 11, Augusta, Georgia, United States
๐บ๐ธSite 3, Valparaiso, Indiana, United States
๐บ๐ธSite 12, Louisville, Kentucky, United States
Safety Study of HPP593 in Subjects During and After Limb Immobilization
- First Posted Date
- 2012-02-02
- Last Posted Date
- 2014-07-15
- Lead Sponsor
- High Point Pharmaceuticals, LLC.
- Target Recruit Count
- 24
- Registration Number
- NCT01524406
- Locations
- ๐บ๐ธ
Washington University School of Medicine Division of Geriatrics and Nutritional Studies, St. Louis, Missouri, United States
Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease
Phase 1
Terminated
- Conditions
- Mild Alzheimer's DiseaseMild Cognitive Impairment
- Interventions
- Drug: Placebo
- First Posted Date
- 2011-11-30
- Last Posted Date
- 2012-08-30
- Lead Sponsor
- High Point Pharmaceuticals, LLC.
- Target Recruit Count
- 7
- Registration Number
- NCT01482013
- Locations
- ๐บ๐ธ
High Point Clinical Trials Center, High Point, North Carolina, United States
๐บ๐ธDuke Clinical Research Unit, Durham, North Carolina, United States
๐บ๐ธElite Research Institute, Miami, Florida, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath